These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Recombinant interferon-alpha-2C in laryngeal papillomatosis: preliminary results of a prospective multicentre trial.
    Author: Zenner HP, Kley W, Clarós P, Clarós A, Labas Z, Löbe LP, Pavelka R, Plath P, Ribari O, Niethammer D.
    Journal: Oncology; 1985; 42 Suppl 1():15-8. PubMed ID: 3909032.
    Abstract:
    A preparation of interferon-alpha 2C of high purity formed by recombinant DNA technology was used as adjuvant therapy following removal of laryngeal papillomas by cauterization or laser vaporization. Preliminary data on 20 patients are reported and include 11 complete and 7 partial responses. Side-effects included initial temperature elevation, but this subsided and other side-effects were uncommon. No antibodies to the interferon preparation were found in any of the patients.
    [Abstract] [Full Text] [Related] [New Search]